Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
H Goossens, M Ferech, R Vander Stichele, M Elseviers - The Lancet, 2005 - thelancet.com
Background Resistance to antibiotics is a major public-health problem and antibiotic use is
being increasingly recognised as the main selective pressure driving this resistance. Our aim …
being increasingly recognised as the main selective pressure driving this resistance. Our aim …
[HTML][HTML] Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
…, J Ellis, M Zambon, M Peiris, H Goossens… - …, 2020 - eurosurveillance.org
Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV)
poses a challenge for public health laboratories as virus isolates are unavailable while there …
poses a challenge for public health laboratories as virus isolates are unavailable while there …
Antibiotic resistance—the need for global solutions
…, E Vlieghe, GL Hara, IM Gould, H Goossens… - The Lancet infectious …, 2013 - thelancet.com
The causes of antibiotic resistance are complex and include human behaviour at many
levels of society; the consequences affect everybody in the world. Similarities with climate …
levels of society; the consequences affect everybody in the world. Similarities with climate …
Seasonal coronavirus protective immunity is short-lasting
…, CM Kinsella, P Rueda, M Ieven, H Goossens… - Nature medicine, 2020 - nature.com
A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is
the duration of acquired immunity. Insights from infections with the four seasonal human …
the duration of acquired immunity. Insights from infections with the four seasonal human …
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Tracking antibiotic consumption patterns over time and across countries could inform policies
to optimize antibiotic prescribing and minimize antibiotic resistance, such as setting and …
to optimize antibiotic prescribing and minimize antibiotic resistance, such as setting and …
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
…, M Lopez-Brea, AM Hirschl, LP Andersen, H Goossens… - Gut, 2013 - gut.bmj.com
Objective Resistance to antibiotics is the major cause of treatment failure of Helicobacter
pylori infection. A study was conducted to assess prospectively the antibacterial resistance …
pylori infection. A study was conducted to assess prospectively the antibacterial resistance …
European position paper on rhinosinusitis and nasal polyps 2012
…, R Douglas, P Gevaert, C Georgalas, H Goossens… - Rhinology, 2012 - biblio.ugent.be
The methodology for EPOS2012 has been the same as for the other two productions. Leaders
in the field were invited to critically appraise the literature and write a report on a subject …
in the field were invited to critically appraise the literature and write a report on a subject …
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Background The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity
and mortality worldwide. Due to its large public health and societal implications, multidrug-…
and mortality worldwide. Due to its large public health and societal implications, multidrug-…
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, EJ Duffy, LJ Estcourt, M Fitzgerald, H Goossens… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
…, M Detry, L Estcourt, M Fitzgerald, H Goossens… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …